{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:16:45Z","timestamp":1793038605920,"version":"4.5.0"},"reference-count":97,"publisher":"European Respiratory Society (ERS)","issue":"165","license":[{"start":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T00:00:00Z","timestamp":1662508800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir Rev"],"accepted":{"date-parts":[[2022,7,4]]},"published-print":{"date-parts":[[2022,9,30]]},"abstract":"<jats:p>Multidisciplinary team (MDT) meetings, involving the integrated collaboration of healthcare professionals, are increasingly used in clinical practice to inform the diagnosis and treatment of interstitial lung diseases (ILDs). Over time, the assessment of patients with ILD has transitioned from discussions among clinicians, radiologists and pathologists to the inclusion of a broader range of clinical data and specialist expertise. Studies have shown that a multidisciplinary approach can have many benefits for the clinical care of patients with ILD by improving the diagnostic confidence for different ILDs and guiding treatment decisions. The utility of MDT discussions for diagnosis, monitoring disease progression and management decisions, will need to be considered based on how it is best positioned in the diagnostic and therapeutic process, as well as the practicality and challenges of its use. There are also uncertainties and heterogeneity concerning the optimal practices of MDT meetings in ILD care. In this review, we describe recent developments refining the approach to MDTs in clinical practice, including who should be involved in the MDTs, when it is most needed, their use in patient management, challenges in their implementation, and ongoing controversies in the field that need further research.<\/jats:p>","DOI":"10.1183\/16000617.0003-2022","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T09:15:47Z","timestamp":1662542147000},"page":"220003","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":58,"title":["Multidisciplinary teams in the clinical care of fibrotic interstitial lung disease: current perspectives"],"prefix":"10.1183","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5591-0955","authenticated-orcid":false,"given":"Vincent","family":"Cottin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando J.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6271-7945","authenticated-orcid":false,"given":"Vanessa","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon L.F.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2022,9,7]]},"reference":[{"key":"2024102404044302000_31.165.220003.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2005230"},{"key":"2024102404044302000_31.165.220003.2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202202-0399ST"},{"key":"2024102404044302000_31.165.220003.3","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00692-2018"},{"key":"2024102404044302000_31.165.220003.4","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0100-2018"},{"key":"2024102404044302000_31.165.220003.5","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2017-000212"},{"key":"2024102404044302000_31.165.220003.6","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.165.2.ats01"},{"key":"2024102404044302000_31.165.220003.7","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201308-1483ST"},{"key":"2024102404044302000_31.165.220003.8","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201807-1255ST"},{"key":"2024102404044302000_31.165.220003.9","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200606-833OC"},{"key":"2024102404044302000_31.165.220003.10","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S2213-2600(16)30033-9","article-title":"Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study","volume":"4","author":"Walsh","year":"2016","journal-title":"Lancet Respir Med"},{"key":"2024102404044302000_31.165.220003.11","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00063706"},{"key":"2024102404044302000_31.165.220003.12","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200402-147OC"},{"key":"2024102404044302000_31.165.220003.13","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2019.00246"},{"key":"2024102404044302000_31.165.220003.14","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1080\/17476348.2020.1784730","article-title":"The extended utility of antifibrotic therapy in progressive fibrosing interstitial lung disease","volume":"14","author":"Sarkar","year":"2020","journal-title":"Expert Rev Respir Med"},{"key":"2024102404044302000_31.165.220003.15","first-page":"108","article-title":"Multidisciplinary management of interstitial lung diseases: a real-life study","volume":"36","author":"Biglia","year":"2019","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2024102404044302000_31.165.220003.16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12931-021-01714-y","article-title":"Comparative outcomes in patients receiving pirfenidone or nintedanib for idiopathic pulmonary fibrosis","volume":"22","author":"Belhassen","year":"2021","journal-title":"Respir Res"},{"key":"2024102404044302000_31.165.220003.17","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0002-2017"},{"key":"2024102404044302000_31.165.220003.18","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ccm.2021.03.013","article-title":"Care delivery models and interstitial lung disease: the role of the specialized center","volume":"42","author":"Fisher","year":"2021","journal-title":"Clin Chest Med"},{"key":"2024102404044302000_31.165.220003.19","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.chest.2020.09.256","article-title":"Essential components of an interstitial lung disease clinic: results from a Delphi survey and patient focus group analysis","volume":"159","author":"Graney","year":"2021","journal-title":"Chest"},{"key":"2024102404044302000_31.165.220003.20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13023-017-0676-3","article-title":"European reference networks for rare diseases: what is the conceptual framework?","volume":"12","author":"Heon-Klin","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"2024102404044302000_31.165.220003.21","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.chest.2021.02.021","article-title":"Identification and remediation of environmental exposures in patients with interstitial lung disease: evidence review and practical considerations","volume":"160","author":"Copeland","year":"2021","journal-title":"Chest"},{"key":"2024102404044302000_31.165.220003.22","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2016-103973"},{"key":"2024102404044302000_31.165.220003.23","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S2213-2600(17)30433-2","article-title":"Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society white paper","volume":"6","author":"Lynch","year":"2018","journal-title":"Lancet Respir Med"},{"key":"2024102404044302000_31.165.220003.24","unstructured":"National Institute for Health and Care Excellence . Idiopathic Pulmonary Fibrosis in Adults: Diagnosis and Management. National Institute for Health and Care Excellence, London, UK , 2017."},{"key":"2024102404044302000_31.165.220003.25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1513\/AnnalsATS.202108-979ED","article-title":"Multidisciplinary meetings in interstitial lung disease: polishing the gold standard","volume":"19","author":"Lee","year":"2022","journal-title":"Ann Am Thorac Soc"},{"key":"2024102404044302000_31.165.220003.26","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/resp.13163","article-title":"The interstitial lung disease multidisciplinary meeting: a position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia","volume":"22","author":"Prasad","year":"2017","journal-title":"Respirology"},{"key":"2024102404044302000_31.165.220003.27","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00206-2020"},{"key":"2024102404044302000_31.165.220003.28","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201504-0711OC"},{"key":"2024102404044302000_31.165.220003.29","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202005-2032ST"},{"key":"2024102404044302000_31.165.220003.30","first-page":"20190009","article-title":"Differential diagnoses of fibrosing lung diseases","volume":"1","author":"Horst","year":"2019","journal-title":"BJR Open"},{"key":"2024102404044302000_31.165.220003.31","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1093\/rheumatology\/keac102","article-title":"Is there a role for nailfold videocapillaroscopy in interstitial lung disease?","volume":"61","author":"Smith","year":"2022","journal-title":"Rheumatology"},{"key":"2024102404044302000_31.165.220003.32","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02026-2019"},{"key":"2024102404044302000_31.165.220003.33","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2018-000782"},{"key":"2024102404044302000_31.165.220003.34","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00131912"},{"key":"2024102404044302000_31.165.220003.35","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1164\/rccm.201702-0400PP","article-title":"A standardized diagnostic ontology for fibrotic interstitial lung disease. An international working group perspective","volume":"196","author":"Ryerson","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102404044302000_31.165.220003.36","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-016-0562-1"},{"key":"2024102404044302000_31.165.220003.37","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1164\/rccm.202111-2607PP","article-title":"Integrating clinical probability into the diagnostic approach to idiopathic pulmonary fibrosis: an international working group perspective","volume":"206","author":"Cottin","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102404044302000_31.165.220003.38","doi-asserted-by":"publisher","DOI":"10.1183\/09059180.00011714"},{"key":"2024102404044302000_31.165.220003.39","doi-asserted-by":"publisher","DOI":"10.1183\/09059180.00004914"},{"key":"2024102404044302000_31.165.220003.40","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1016\/j.chest.2021.03.066","article-title":"Diagnosis and evaluation of hypersensitivity pneumonitis: CHEST guideline and expert panel report","volume":"160","author":"Fernandez Perez","year":"2021","journal-title":"Chest"},{"key":"2024102404044302000_31.165.220003.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2010.03.019"},{"key":"2024102404044302000_31.165.220003.42","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3390\/jcm5080066","article-title":"A review of the multidisciplinary diagnosis of interstitial lung diseases: a retrospective analysis in a single UK specialist centre","volume":"5","author":"Chaudhuri","year":"2016","journal-title":"J Clin Med"},{"key":"2024102404044302000_31.165.220003.43","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200906-0959OC"},{"key":"2024102404044302000_31.165.220003.44","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1016\/j.ejrad.2015.08.016","article-title":"Diagnostic certainty of idiopathic pulmonary fibrosis\/usual interstitial pneumonia: the effect of the integrated clinico-radiological assessment","volume":"84","author":"Tominaga","year":"2015","journal-title":"Eur J Radiol"},{"key":"2024102404044302000_31.165.220003.45","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.chest.2018.03.026","article-title":"Diagnostic ability of a dynamic multidisciplinary discussion in interstitial lung diseases: a retrospective observational study of 938 cases","volume":"153","author":"De Sadeleer","year":"2018","journal-title":"Chest"},{"key":"2024102404044302000_31.165.220003.46","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1111\/resp.12850","article-title":"Clinical impact of the interstitial lung disease multidisciplinary service","volume":"21","author":"Jo","year":"2016","journal-title":"Respirology"},{"key":"2024102404044302000_31.165.220003.47","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1164\/rccm.201608-1675PP","article-title":"Diagnosis and treatment of fibrotic hypersensitivity pneumonia. Where we stand and where we need to go","volume":"196","author":"Salisbury","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102404044302000_31.165.220003.48","doi-asserted-by":"crossref","first-page":"00209-02018","DOI":"10.1183\/23120541.00209-2018","article-title":"The characterisation of interstitial lung disease multidisciplinary team meetings: a global study","volume":"5","author":"Richeldi","year":"2019","journal-title":"ERJ Open Res"},{"key":"2024102404044302000_31.165.220003.49","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1113354"},{"key":"2024102404044302000_31.165.220003.50","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S2213-2600(21)00354-4","article-title":"Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"10","author":"Naccache","year":"2022","journal-title":"Lancet Respir Med"},{"key":"2024102404044302000_31.165.220003.51","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.3390\/jcm9061722","article-title":"Towards the essence of progressiveness: bringing progressive fibrosing interstitial lung disease (PF-ILD) to the next stage","volume":"9","author":"De Sadeleer","year":"2020","journal-title":"J Clin Med"},{"key":"2024102404044302000_31.165.220003.52","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00085-2020"},{"key":"2024102404044302000_31.165.220003.53","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30355-6"},{"key":"2024102404044302000_31.165.220003.54","doi-asserted-by":"crossref","first-page":"6452","DOI":"10.1038\/s41598-019-42813-7","article-title":"The role of follow-up evaluation in the diagnostic algorithm of idiopathic interstitial pneumonia: a retrospective study","volume":"9","author":"Han","year":"2019","journal-title":"Sci Rep"},{"key":"2024102404044302000_31.165.220003.55","doi-asserted-by":"publisher","DOI":"10.1002\/art.40130"},{"key":"2024102404044302000_31.165.220003.56","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00357-2015"},{"key":"2024102404044302000_31.165.220003.57","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/acr2.11253","article-title":"Detection and management of interstitial lung diseases associated with connective tissue diseases","volume":"3","author":"Castelino","year":"2021","journal-title":"ACR Open Rheumatol"},{"key":"2024102404044302000_31.165.220003.58","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0008-2017"},{"key":"2024102404044302000_31.165.220003.59","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1164\/rccm.201803-0444PP","article-title":"Computed tomographic biomarkers in idiopathic pulmonary fibrosis. The future of quantitative analysis","volume":"199","author":"Wu","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102404044302000_31.165.220003.60","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908681"},{"key":"2024102404044302000_31.165.220003.61","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S2213-2600(20)30554-3","article-title":"Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial","volume":"9","author":"Behr","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2024102404044302000_31.165.220003.62","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S2213-2600(19)30341-8","article-title":"Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"8","author":"Maher","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2024102404044302000_31.165.220003.63","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02533-2020"},{"key":"2024102404044302000_31.165.220003.64","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1055\/s-0039-1684020","article-title":"Multidisciplinary evaluation in patients with lung disease associated with connective tissue disease","volume":"40","author":"Wells","year":"2019","journal-title":"Semin Respir Crit Care Med"},{"key":"2024102404044302000_31.165.220003.65","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1903076"},{"key":"2024102404044302000_31.165.220003.66","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/art.41933","article-title":"Systemic sclerosis-associated interstitial lung disease: how to incorporate two food and drug administration-approved therapies in clinical practice","volume":"74","author":"Khanna","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"2024102404044302000_31.165.220003.67","unstructured":"US Food and Drug Administration . Actemra (tocilizumab): prescribing information. www.accessdata.fda.gov\/drugsatfda_docs\/label\/2013\/125276s092lbl.pdf Date last updated: October 2013."},{"key":"2024102404044302000_31.165.220003.68","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/resp.13913","article-title":"Priorities and expectations of patients attending a multidisciplinary interstitial lung disease clinic","volume":"26","author":"McLean","year":"2021","journal-title":"Respirology"},{"key":"2024102404044302000_31.165.220003.69","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jpainsymman.2017.10.016","article-title":"Beyond idiopathic pulmonary fibrosis diagnosis: multidisciplinary care with an early integrated palliative approach is associated with a decrease in acute care utilization and hospital deaths","volume":"55","author":"Kalluri","year":"2018","journal-title":"J Pain Symptom Manage"},{"key":"2024102404044302000_31.165.220003.70","doi-asserted-by":"crossref","first-page":"5601","DOI":"10.1093\/rheumatology\/keab154","article-title":"Identifying unmet needs in SSc-ILD by semi-qualitative in-depth interviews","volume":"60","author":"Hoffmann-Vold","year":"2021","journal-title":"Rheumatology"},{"key":"2024102404044302000_31.165.220003.71","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s10067-018-4358-x","article-title":"Optimal care for systemic sclerosis patients: recommendations from a patient-centered and multidisciplinary mixed-method study and working conference","volume":"38","author":"Spierings","year":"2019","journal-title":"Clin Rheumatol"},{"key":"2024102404044302000_31.165.220003.72","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01204-2015"},{"key":"2024102404044302000_31.165.220003.73","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S2213-2600(18)30502-2","article-title":"Lung transplantation for idiopathic pulmonary fibrosis","volume":"7","author":"George","year":"2019","journal-title":"Lancet Respir Med"},{"key":"2024102404044302000_31.165.220003.74","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1513\/AnnalsATS.202011-1421OC","article-title":"Essential features of an interstitial lung disease multidisciplinary meeting: an international Delphi survey","volume":"19","author":"Teoh","year":"2022","journal-title":"Ann Am Thorac Soc"},{"key":"2024102404044302000_31.165.220003.75","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00936-2017"},{"key":"2024102404044302000_31.165.220003.76","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1601827113"},{"key":"2024102404044302000_31.165.220003.77","doi-asserted-by":"publisher","DOI":"10.2147\/JMDH.S117945"},{"key":"2024102404044302000_31.165.220003.78","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S2213-2600(18)30023-7","article-title":"Validation of multidisciplinary diagnosis in IPF","volume":"6","author":"Castillo","year":"2018","journal-title":"Lancet Respir Med"},{"key":"2024102404044302000_31.165.220003.79","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.chest.2018.05.044","article-title":"Should patients with interstitial lung disease be seen by experts?","volume":"154","author":"Cottin","year":"2018","journal-title":"Chest"},{"key":"2024102404044302000_31.165.220003.80","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/17571472.2008.11493220","article-title":"Myths and realities in multidisciplinary team-working","volume":"1","author":"Iliffe","year":"2008","journal-title":"London J Prim Care"},{"key":"2024102404044302000_31.165.220003.81","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-016-0179-3"},{"key":"2024102404044302000_31.165.220003.82","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02243-2018"},{"key":"2024102404044302000_31.165.220003.83","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/resp.14062","article-title":"Benefits of a virtual interstitial lung disease multidisciplinary meeting in the face of COVID-19","volume":"26","author":"Mackintosh","year":"2021","journal-title":"Respirology"},{"key":"2024102404044302000_31.165.220003.84","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1513\/AnnalsATS.201811-794OC","article-title":"Role of a regional multidisciplinary conference in the diagnosis of interstitial lung disease","volume":"16","author":"Grewal","year":"2019","journal-title":"Ann Am Thorac Soc"},{"key":"2024102404044302000_31.165.220003.85","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2008.101691"},{"key":"2024102404044302000_31.165.220003.86","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.rmr.2022.01.005","article-title":"French practical guidelines for the diagnosis and management of IPF-2021 update, short version","volume":"39","author":"Cottin","year":"2022","journal-title":"Rev Mal Respir"},{"key":"2024102404044302000_31.165.220003.87","unstructured":"Autorit\u00e9 de Sant\u00e9 Haute . Fibrose pulmonaire idiopathique. www.has-sante.fr\/jcms\/p_3278607\/fr\/fibrose-pulmonaire-idiopathique Date last updated: 28 July 2021."},{"key":"2024102404044302000_31.165.220003.88","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.chest.2021.03.067","article-title":"Executive summary: diagnosis and evaluation of hypersensitivity pneumonitis: CHEST guideline and expert panel report","volume":"160","author":"Fernandez Perez","year":"2021","journal-title":"Chest"},{"key":"2024102404044302000_31.165.220003.89","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/resp.13977","article-title":"Diagnosis and management of connective tissue disease-associated interstitial lung disease in Australia and New Zealand: a position statement from the Thoracic Society of Australia and New Zealand","volume":"26","author":"Jee","year":"2021","journal-title":"Respirology"},{"key":"2024102404044302000_31.165.220003.90","first-page":"133","article-title":"Evaluation of patients with fibrotic interstitial lung disease: a Canadian Thoracic Society position statement","volume":"1","author":"Johannson","year":"2017","journal-title":"Can J Respir Crit Care Sleep Med"},{"key":"2024102404044302000_31.165.220003.91","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2009.02.009"},{"key":"2024102404044302000_31.165.220003.92","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq233"},{"key":"2024102404044302000_31.165.220003.93","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2016-208776"},{"key":"2024102404044302000_31.165.220003.94","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.171314"},{"key":"2024102404044302000_31.165.220003.95","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fmed.2020.00011","article-title":"Multidisciplinary approach in the early detection of undiagnosed connective tissue diseases in patients with interstitial lung disease: a retrospective cohort study","volume":"7","author":"Tirelli","year":"2020","journal-title":"Front Med"},{"key":"2024102404044302000_31.165.220003.96","doi-asserted-by":"crossref","first-page":"9026171","DOI":"10.1155\/2020\/9026171","article-title":"The impact of multidisciplinary discussion (MDD) in the diagnosis and management of fibrotic interstitial lung diseases","volume":"2020","author":"Ageely","year":"2020","journal-title":"Can Respir J"},{"key":"2024102404044302000_31.165.220003.97","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3390\/diagnostics10090664","article-title":"Multidisciplinary evaluation of interstitial lung diseases: new opportunities linked to rheumatologist involvement","volume":"10","author":"De Lorenzis","year":"2020","journal-title":"Diagnostics"}],"container-title":["European Respiratory Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/16000617.0003-2022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:05:16Z","timestamp":1740373516000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/16000617.0003-2022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,7]]},"references-count":97,"journal-issue":{"issue":"165","published-online":{"date-parts":[[2022,9,7]]},"published-print":{"date-parts":[[2022,9,30]]}},"alternative-id":["10.1183\/16000617.0003-2022"],"URL":"https:\/\/doi.org\/10.1183\/16000617.0003-2022","relation":{},"ISSN":["0905-9180","1600-0617"],"issn-type":[{"value":"0905-9180","type":"print"},{"value":"1600-0617","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,7]]}}}